These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 8447345)

  • 21. Lucrative niches: how drugs for rare diseases became lifeline for companies.
    Anand G
    Wall St J (East Ed); 2005 Nov; ():A1, A18. PubMed ID: 16502531
    [No Abstract]   [Full Text] [Related]  

  • 22. Medicaid program; time limitation on price recalculations and recordkeeping requirements under the drug rebate program. Final rule with comment period.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2003 Aug; 68(168):51912-7. PubMed ID: 12962118
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The MAC program and advisors to the government.
    Shubin S
    Hosp Formul; 1981 Aug; 16(8):869-72, 877-9. PubMed ID: 10252371
    [No Abstract]   [Full Text] [Related]  

  • 24. Industry warily eyes new Medicare drug plan.
    Vastag B
    Nat Biotechnol; 2006 Feb; 24(2):120. PubMed ID: 16465141
    [No Abstract]   [Full Text] [Related]  

  • 25. "Insuring" the continued solvency of pharmaceutical companies in the face of product liability class actions.
    Chodock R; Yolkut D; Connolly DR
    Tort Trial Insur Pract Law J; 2005; 40(3):997-1017. PubMed ID: 16100814
    [TBL] [Abstract][Full Text] [Related]  

  • 26. State and federal government mandates are changing the face of pharmacy management.
    Giaquinta D
    Manag Care Interface; 2001 May; 14(5):50-2. PubMed ID: 11385948
    [No Abstract]   [Full Text] [Related]  

  • 27. Medicare overpaid dollar 110 million for part B drugs.
    Med Health; 2006 Mar; 60(13):2-3. PubMed ID: 16562555
    [No Abstract]   [Full Text] [Related]  

  • 28. A prescription for better prescriptions.
    Woosley RL
    Issues Sci Technol; 1994; 10(3):59-66. PubMed ID: 10133487
    [No Abstract]   [Full Text] [Related]  

  • 29. Pharmaceuticals and medical devices: Medicare Part D. End-of-year issue brief.
    Chaps NA
    Issue Brief Health Policy Track Serv; 2008 Jan; ():1-23. PubMed ID: 18345558
    [No Abstract]   [Full Text] [Related]  

  • 30. Medicaid reimbursement. Issue brief.
    Berry MD
    Issue Brief Health Policy Track Serv; 2009 Jan; ():1-13. PubMed ID: 19297676
    [No Abstract]   [Full Text] [Related]  

  • 31. Forecasting the future.
    Tecnologica; 1999 Dec; ():1, 3-6, 14-5. PubMed ID: 10848110
    [No Abstract]   [Full Text] [Related]  

  • 32. Health Care Financing Administration: Pharmaceutical Reimbursement Board; final maximum allowable cost determinations.
    Fed Regist; 1979 Aug; 44(169):50651-6. PubMed ID: 10297564
    [No Abstract]   [Full Text] [Related]  

  • 33. Reimbursement for outpatient biotech drugs, Part 1.
    Dasher T
    Am Pharm; 1993 Jul; NS33(7):16-7. PubMed ID: 8342488
    [No Abstract]   [Full Text] [Related]  

  • 34. Pharmaceuticals: Medicare Modernization Act.
    Hilyard K; Howe WC
    Issue Brief Health Policy Track Serv; 2007 Jan; ():1-28. PubMed ID: 17361467
    [No Abstract]   [Full Text] [Related]  

  • 35. Your next move in managing drug costs.
    Heenan J
    Bus Health; 1995 Aug; 13(8):31-2, 36, 38. PubMed ID: 10153416
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PBMs to the rescue? Pharmacy benefit managers will play a key role in the Medicare drug benefit. What does it mean for the industry, consumers and Uncle Sam?
    Fong T
    Mod Healthc; 2005 Nov; 35(48):26-8, 30. PubMed ID: 16617721
    [No Abstract]   [Full Text] [Related]  

  • 37. Support system: through charities, drug makers help people--and themselves.
    Anand G
    Wall St J (East Ed); 2005 Dec; ():A1, A10. PubMed ID: 16502554
    [No Abstract]   [Full Text] [Related]  

  • 38. Doubts emerge about drug industry mergers.
    Bus Health; 1994 Nov; 12(11):53-4, 56, 61. PubMed ID: 10138536
    [No Abstract]   [Full Text] [Related]  

  • 39. New rules for US drug reimbursement.
    Bouchie A
    Nat Biotechnol; 2003 Oct; 21(10):1119-20. PubMed ID: 14520382
    [No Abstract]   [Full Text] [Related]  

  • 40. Medicaid reimbursement.
    Berry MD
    Issue Brief Health Policy Track Serv; 2008 Jan; ():1-31. PubMed ID: 18345577
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.